In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Clinical approach to cardio-oncological patient
Session

Congress : Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic : Cardiotoxicity of Drugs and Other Therapies

  • Session type : Symposium
  • Date : 28 May 2019
  • Time : 08:30 - 10:00

5 presentations in this session

Early detection of cardio-toxicity: the role of imaging.

Congress : Heart Failure 2019

  • Session : Clinical approach to cardio-oncological patient
  • Speaker : T Lopez Fernandez (Madrid,ES)

Early detection of cardio-toxicity: the role of biomarkers.

Congress : Heart Failure 2019

  • Session : Clinical approach to cardio-oncological patient
  • Speaker : D Cardinale (Milan,IT)

Prevention of cardiotoxicity.

Congress : Heart Failure 2019

  • Session : Clinical approach to cardio-oncological patient
  • Speaker : K Keramida (Athens,GR)

Medical Interventions.

Congress : Heart Failure 2019

  • Session : Clinical approach to cardio-oncological patient
  • Speaker : R De Boer (Groningen,NL)

How to start a cardio-oncology service.

Congress : Heart Failure 2019

  • Session : Clinical approach to cardio-oncological patient
  • Speaker : A Lyon (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are